Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients

SIMPLE SUMMARY: Non-small cell lung cancer (NSCLC) with Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) mutation comprises a specific subgroup of patients who are particular in terms of several clinical and molecular aspects. Indeed, there is a clear medical need to find specific and effective tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Francesca, Cani, Massimiliano, Malapelle, Umberto, Novello, Silvia, Napoli, Valerio Maria, Bironzo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699276/
https://www.ncbi.nlm.nih.gov/pubmed/34944952
http://dx.doi.org/10.3390/cancers13246332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699276/
https://www.ncbi.nlm.nih.gov/pubmed/34944952
http://dx.doi.org/10.3390/cancers13246332

Ejemplares similares